Journal of Pharmacology and Drug Development
Login
JPDD
  • Home
  • Articles & Issues
    • Latest Issue
    • All Issues
  • Authors
    • Submit Manuscript
    • Guide for Authors
    • Author Resources
    • Authorship
    • Article Processing Charges (APC)
  • Reviewers
    • Guide for Reviewers
    • Become a Reviewer
  • About
    • About Journal
    • Aims and Scope
    • Editorial Team
    • Journal Insights
    • Peer Review Process
    • Publication Ethics
    • Plagiarism
    • Allegations of Misconduct
    • Appeals and Complaints
    • Corrections and Withdrawals
    • Open Access
    • Archiving Policy
    • Announcements
    • Contact

Search Results for Saba Hameed Majeed

Article
Comparison of sitagliptin, glimepiride, and metformin group with glimepiride and metformin group in treatment of diabetes mellitus type 2 patients

Mohammed Fareed Hameed, Saba Hameed Majeed

Pages: 6-10

PDF Full Text
Abstract

Objective: To compare glycaemia control between glimepiride and metformin group with sitagliptin, glimepiride and metformin group in uncontrolled type 2 diabetic patient. Methods: This retrospective, randomized, clinical study was done in the diabetes research center. The number of the patient in this study was thirty-five patients. The patients examined individually in detail to check their general health in addition to the physical state. For all the patients, data had been collected and fasting plasma glucose level had been measured. Participants have been chosen by unresponsiveness of diabetic patient to single therapy of metformin or glimepiride in this trial. The patients were allocated into 2 groups. Group I include 14 patient given glimepiride, metformin and sitagliptin, while group II include 21 patients given glimepiride and metformin. Both Results: A statistical significant decrease was found in fasting plasma glucose level when compare before and after treatment regimen of sitagliptin, Glimepiride and Metformin group while no significant difference in fasting plasma glucose when comparing the triple therapy group (Sitagliptin, Glimepiride and Metformin) with the double therapy group (Glimepiride and Metformin) after thirty days of treatment. groups continue treatment for thirty days and statistical analyses include data collection was done. Conclusion: No significant difference was found between glimepiride and metformin therapy with sitagliptin, glimepiride and metformin therapy in uncontrolled type 2 diabetic patient.

Article
Does Having a Smoking Friend or Parent Encourage Baghdad Medical Students to Smoke

Saba Hameed Majeed, Mohammed Murtadha, Ahmed Mohammed Ahmed Alcharrakh

Pages: 44-52

PDF Full Text
Abstract

Objective: worldwide to lessen the impact of the tobacco pandemic. A major roadblock to reducing tobacco consumption is the absence of smoking statistics in the Iraqi population. The study set out to answer the question, " Does having a smoking friend or parent encourage Baghdad Medical students to smoke?" by looking for a correlation between social contacts and smoking behaviors within the demographic and the prevalence of smoking among medical students. Methods: This work uses cross-sectional studies to investigate the effects of social and familial elements as well as their consequences for public health policies. Students' one-on-one encounters in healthcare environments provided the data for the cross-sectional observational study. Comprising 599 college students ranging in age from 18 to 23, the sample included two groups of smoking and nonsmoking individuals. Conclusions: This study intends to investigate how friends and parents’ behavior affect medical students from Baghdad's smoking behavior. The data showed a significant relationship among the smoking group who already had a parent or a friend who smokes. The study recommends a new anti-smoking campaign focused on the medical students. Stressing the need for robust and resilient training and awareness efforts to reduce this phenomenon.

1 - 2 of 2 items

Search Parameters

Journal Logo
Journal of Pharmacology and Drug Development

College of Pharmacy | Al-Nahrain University

  • Copyright Policy
  • Terms & Conditions
  • Privacy Policy
  • Accessibility
  • Cookie Settings
Licensing & Open Access

CC BY 4.0 Logo Licensed under CC-BY-4.0

This journal provides immediate open access to its content.

Editorial Manager Logo Elsevier Logo

Peer-review powered by Elsevier’s Editorial Manager®

Copyright © 2025 College of Pharmacy, Al-Nahrain University. All rights reserved, including those for text and data mining, AI training, and similar technologies.